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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYIt is clear that neural differentiation from human pluripotent stem cells generates cells that are developmentally immature. Here, we
show that the let-7 plays a functional role in the developmental decisionmaking of humanneural progenitors, controllingwhether these
cells make neurons or glia. Through gain- and loss-of-function studies on both tissue and pluripotent derived cells, our data show that let-
7 specifically regulates decision making in this context by regulation of a key chromatin-associated protein, HMGA2. Furthermore, we
provide evidence that the let-7/HMGA2 circuit acts on HES5, a NOTCH effector and well-established node that regulates fate decisions
in the nervous system. These data link the let-7 circuit to NOTCH signaling and suggest that this interaction serves to regulate human
developmental progression.INTRODUCTION
We previously determined that, by both gene expression
and functional analyses, the derivatives of human pluripo-
tent stem cells (hPSCs) more closely resembled cell types
found prior to 6 weeks of gestation than later time points
(Patterson et al., 2012). In fact, this appears to be an
emerging theme in hPSC differentiation (Chang et al.,
2011; Mariani et al., 2012; Zambidis et al., 2005). This sug-
gests that hPSC derivatives are developmentally immature,
which could stem from either inadequate culturing
methods or could suggest that developmental timing is
somewhat conserved in vitro.
Among the most differentially expressed genes in all
PSC derivatives are LIN28A and LIN28B, RNA binding
proteins known to regulate the let-7 family of miRNAs
(Patterson et al., 2012). LIN28B seems to function primar-
ily in the nucleus by sequestering pri-let-7s to prevent
maturation by Microprocessor, whereas LIN28A functions
in the cytoplasm by recruiting uridylyl transferase to pol-
yuridylate the pre-let-7s and prevent their further process-
ing by Dicer (Graf et al., 2013; Hagan et al., 2009; Kim
and Nam, 2006; Lee et al., 2014; Piskounova et al.,
2011). In lower organisms, Lin28A expression is strongly
correlated with the differentiation status and self-renew-
ing capacity of cells throughout development. Although
there is less evidence for the role of this pathway in hu-
man development specifically, many groups have demon-
strated that LIN28A is reexpressed in a variety of human
cancers and is highly correlated with prognosis and dis-758 Stem Cell Reports j Vol. 3 j 758–773 j November 11, 2014 j ª2014 Theease progression (Viswanathan and Daley, 2010; West
et al., 2009). Furthermore, LIN28A has also been used to
reprogram somatic cells back to the pluripotent state
(Yu et al., 2007). All of these known roles are linked
to developmental progression and make LIN28A/B-let-7
an attractive candidate for manipulating the maturity of
hPSC-derived cells.
Previous work by other groups in lower organisms has
argued that Lin28A plays a role in maturation of the ner-
vous system (Balzer et al., 2010), and some have shown
that overexpression of LIN28B in human adult hematopoi-
etic stem/progenitor cells can reverse their developmental
progression to a fetal-like state (Yuan et al., 2012). Down-
stream of LIN28A/B, however, a role for let-7 in human
gestational maturation in the nervous system has not
been established. In fact, one study of a murine model
has suggested that the role of Lin28A in developmental pro-
gression was let-7 independent (Balzer et al., 2010). Recent
work has also suggested that LIN28/let-7 regulates neuro-
genesis by controlling the proliferation of progenitors (Ci-
madamore et al., 2013; Nishino et al., 2013). Here, we
explore the role of the LIN28/let-7 pathway in the develop-
mental progression of human neural progenitor cells
(NPCs). We demonstrate that LIN28B plays a clear role in
gestational progression of the developing human nervous
system through regulation of let-7miRNAs. These miRNAs
then go on to regulate HMGA2, which has also been impli-
cated in developmental progression (Sanosaka et al., 2008).
We also showhere thatHMGA2 appears to regulate cell-fate
decisions in neural progenitors (NPCs) in this contextAuthors
Stem Cell Reports
A Role for let-7 in Human Developmental ProgressionthroughHES5, a key node in the NOTCH pathway and pre-
viously implicated in neurogenesis.RESULTS
PSC-NPCs Are Functionally and Transcriptionally
Distinct from Tissue-Derived Counterparts
During mammalian development, NPCs progress through
several phases: an early expansion phase, characterized
by symmetric divisions; a neurogenic phase, characterized
by asymmetric divisions and resulting in new neurons; a
gliogenic phase where astrocytes are primarily produced;
and finally a phase where oligodendrocytes are generated
(Figure 1). The result is that neurogenesis precedes gliogen-
esis on a developmental timescale.
NPCs were derived from either hPSCs or from fetal tis-
sue sources and were validated by immunostaining and
judged to be relatively homogenous (Figure S1A; Patterson
et al., 2012). We determined that PSC-NPCs across all
passages had a higher propensity to differentiate into
MAP2/TUJ1+ neurons (50%) over GFAP/S100/A2B5+
glia (<10%) (Figure 1A). Meanwhile, tissue-derived NPCs
isolated from fetal brain or spinal cord samples at 12–
19 weeks of gestation (Tissue-NPCs) were more apt to
differentiate into glia (70%) over neurons (<20%) (Fig-
ure 1A; Patterson et al., 2012). These data suggest that
PSC-NPCs were functionally less mature than tissue-
derived counterparts (neurogenesis precedes gliogenesis).
Furthermore, we have previously shown that upon subse-
quent passage of PSC-NPCs the propensity for gliogenesis
increased but still did not approach that of tissue-derived
cells (Patterson et al., 2012).
To understand themolecular basis for this observed func-
tional discrepancy, gene expression profiling was per-
formed on PSC derivatives and tissue-derived counterparts
(Patterson et al., 2012). Among the most differentially ex-
pressed genes were LIN28A and LIN28B (Figures 1B, top,
and S1C), and this was confirmed at the protein level by
immunostaining (Figure 1B, bottom). Although continued
passaging reduces the levels of LIN28A and LIN28B in
PSC-NPCs, their expression is not decreased to a level
found in the Tissue-NPCs within the time points utilized
for this study (Figure 1B; Patterson et al., 2012).
LIN28 homologs are known to negatively regulate the
highly conserved let-7 family of miRNAs. Our previous
microarray analyses demonstrated a significantly higher
expression of some let-7 miRNAs in Tissue-NPCs (Fig-
ure S1C), and this result was confirmed by direct
sequencing of mature miRNA (Figure 1C; Table S1). The
latter analysis demonstrated that not only were all let-7
family members significantly higher in Tissue-NPCs, as
we had previously shown by RT-PCR (Patterson et al.,Stem Cell R2012), but all nine family members were found among
the top 30 differentially expressed miRNAs between
Tissue-NPCs and PSC-NPCs (Table S1). Furthermore, the
let-7 family as a whole was the most abundantly expressed
miRNA family in 16 week Tissue-NPCs, representing
almost 18% of the total miRNA in these cells. In addition,
let-7 family members were expressed at an intermediate
level in 6–7 week Tissue-NPCs.
To determine whether let-7 target genes were among the
differentially expressed mRNA distinguishing PSC-NPCs
from their tissue-derived counterparts, two lists of let-7
targets were generated (Figure 1D): one with published
let-7 targets that have been experimentally confirmed
(77 genes) and one with predicted let-7 targets generated
by TargetScan 5.2 (751 genes). Of the 77 published let-7 tar-
gets, 20 were differentially expressed between PSC-NPCs
and Tissue-NPCs, and 134 of the 751 TargetScan predicted
let-7 targets were differentially expressed. Notably, 95%
and 63%, respectively, were specifically lower in Tissue-
NPCs, consistent with a negative regulatory activity of
let-7 in tissue-NPCs.
Recent work inmice has suggested that during neurogen-
esis, the induction of let-7 leads to exit of the cell cycle and
differentiation toward neurons (Cimadamore et al., 2013;
Nishino et al., 2013). Analysis of eight tissue-derived
NPCs and three PSC-derived NPCs failed to find consistent
differences in the percentage of cells in S or G2/M phase of
the cell cycle (Figure 1E), suggesting that despite having
orders of magnitude more let-7 (Figure 1C), Tissue-NPCs
can still maintain a proliferative state.
To determine when the transition from neurogenesis
to gliogenesis occurs endogenously, we probed develop-
mental transcriptome data for glial hallmark genes from
the Allen Brain Atlas. GFAP, AQP4, and S100B were all ex-
pressed at a low level in all brain regions prior to 12 weeks
but surged thereafter suggesting that gliogenesis begins
in the human brain at roughly 12 weeks of gestation. A
similar examination of oligodendrocyte markers suggests
that oligodendrogenesis begins at 24 weeks (Figure 1F,
middle). These gene expression data are consistent with
pathological data on fetal tissue showing oligodendrocyte
progenitors prevalent at 20 weeks of gestation and mature
oligodendrocytes at 30 weeks (Craig et al., 2003; Dean
et al., 2011; Jakovcevski et al., 2009). Notably, the expres-
sionofLIN28B inhumanbrainwasonlydetectable inweeks
8–9 of gestation and dropped off significantly thereafter
(Figure 1F, middle), whereas LIN28A was undetectable in
these analyses. let-7 miRNAs were also detectable in these
data sets, and this family showed a striking induction across
the human brain in the 9–12 postconception week (PCW)
time frame (Figure S1B). Taken together, these data sug-
gested that there is a strong correlation between the transi-
tion from highLIN28/lowlet-7 to lowLIN28/highlet7 stateeports j Vol. 3 j 758–773 j November 11, 2014 j ª2014 The Authors 759
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pothesized that the let-7 plays a functional role in the deci-
sion to make either neurons or glia by neural progenitors
(Figure 1G).
let-7 Expression and Processing across Development
LIN28A/B controls the maturation step to generate mature
let-7 (Hagan et al., 2009; Piskounova et al., 2008, 2011; Vis-
wanathan et al., 2008), and LIN28A and B are also let-7 tar-
gets. A priori, we expected that levels of let-7 rose during
development as a result of LIN28A/B downregulation over
time. Tounderstand thedynamics of let-7processing during
development, we assessed the levels of pri, pre, and mature
let-7 miRNAs (Figure 2), we used RT-PCR to detect specif-
ically mature let-7 family members in NPCs and found
that, similar to what was found by miRNA sequencing
(miRNA-seq) profiling (Figure 1D), all let-7 family members
were dramatically higher in Tissue-NPCs compared to PSC-
NPCs (Figure 2A; Patterson et al., 2012). Conversely, by
using a miRNA RT-PCR approach that strictly measures
primary let-7 transcripts, we determined that pri-let-7b and
pri-let-7a2 transcript levels are significantly higher in
Tissue-NPCs, whereas all the other tested members of the
let-7 family were essentially unchanged (Figure 2C). Simi-
larly, a separate approach that can distinguish pri- and pre-
let-7 messages from mature let-7 miRNAs also showed that
pre-let-7b was the only let-7 family member assayed that
was differentially expressed inTissue- versus PSC-NPCs (Fig-
ure 2B). Interestingly, let-7b and let-7a3 are known to be
expressed from the same locus (Wang et al., 2012), whereas
let-7a1 and let-7a2 are transcribed from different loci.
Passaging of PSC-NPCs results in a decrease of both
LIN28A and LIN28B (Figure 1B; Patterson et al., 2012)Figure 1. let-7 Activity Correlates with Human Gliogenesis
(A) Differentiation of human NPCs by growth factor withdrawal drive
PSC-NPCs and Tissue-NPCs (7–19 weeks of gestation) undergoing neuro
Error bars represent standard error of the mean (SEM) over three at le
(B) Average expression of LIN28A and LIN28B probe sets from (Patters
p4 (n = 2), 6–8 week tissue-NPCs (n = 6), 15–19 week fetal NPCs (n = 5
100 mm.
(C) Percentage of contribution of let-7 miRNA family members to all
6–7 week Tissue-NPCs (n = 2), and PSC-NPCs (n = 3) by miRNA-seq. Fold
PSC-NPCs for each family member is shown at right. Data for all miRN
(D) Genes differentially expressed between PSC-NPCs (n = 7) and Tissu
of let-7 targets represented in the data. let-7 target lists were genera
(E) Despite having significantly different levels of let-7, PSC- and Tissu
analysis based on propidium iodide staining and flow cytometry.
(F) RNA-seq data from the Allen Institute’s Brainspan developm
kilobase measured (log2 RPKM) across the developing human brain. To
(the average of all markers indicated by boldface line); middle, tran
genes.
(G) Top, schematic of LIN28’s role in the progression of let-7microRNAs
differentiation propensity of NPCs correlated with gestational age.
Stem Cell Rand increase of mature let-7s (Figure 2E; Patterson et al.,
2012), suggesting a functional link between LIN28 expres-
sion and levels of mature let-7 as expected (Hagan et al.,
2009; Heo et al., 2008). Interestingly, when assaying for
pri-miRNA transcripts, many of the pri-let-7s were also
induced during passaging as detected by both RT-PCR
(Figure 2F) and Chromatin-RNA-seq (discussed more
below; Figure 2G), which presumably occurred indepen-
dently of any direct regulation by LIN28 protein, because
they are not thought to play any role in regulation of
transcription of pri-let-7s. These results point toward the
existence of undescribed regulatory mechanisms govern-
ing let-7 transcription independent of LIN28 during hu-
man gestation.
To further verify the apparent transcriptional regulation
of the let-7 family, we employed an approach whereby
chromatin-associated RNA is captured and sequenced
(Bhatt et al., 2012). This approach generates data on rela-
tive amounts of nascent transcript, and therefore a bona
fide measure of transcription as opposed to steady-state
levels of RNA. Consistent with results from RT-PCR, tran-
scription at the let-7a3/let-7b locus was significantly
different between PSC-NPCs and Tissue-NPCs, demon-
strating a LIN28A/B independent regulation of let-7 (Fig-
ures 2D and 2G). These data also suggest that the let-7
family of miRNAs is each subject to unique modes of tran-
scriptional regulation that occurs prior to the actions of
LIN28A/B on let-7maturation. Also shown is the expression
of several unrelated miRNAs (miR-10, 15A, 15B) to demon-
strate that the let-7 effect is specific to this family and not
indicative of imbalanced analysis (Figure 2G). This method
allowed for a complete annotation of human let-7 tran-
scriptional loci based on analysis of transcribed RNA, ass the generation of neurons and astrocytes. Percentage of positive
nal (TUJ1, MAP2) versus glial (GFAP, S100B, A2B5) differentiation.
ast three biological replicates.
on et al., 2012). PSC-NPCs p1 (n = 7), PSC-NPCs p2 (n = 2), PSC-NPCs
). Error bars represent SEM over biological replicate lines. Scale bars,
miRNA present in cells derived from 16 week Tissue-NPCs (n = 2),
change of normalized expression between 16 week Tissue-NPCs and
As can be found in Table S1.
e-NPCs (n = 5) as identified (Patterson et al., 2012) and the number
ted from published articles and TargetScan 5.2.
e-NPCs show similar proliferative potential as measured by cell-cycle
ental transcriptome database displayed as log-scale reads per
p, transcription of neuronal, glial and oligodendrocyte marker genes
scription of LIN28B; bottom, transcription of selected let-7 target
and the pathway’s temporal correlation with development. Bottom,
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of polycistronic expression of groups of let-7 family mem-
bers (Table S2).
Manipulation of LIN28A/B Shows a Modest Effect on
Developmental Maturity of NPCs
To determine what role LIN28 had on the developmental
maturity of NPCs, we utilized two strategies. First, we
used a small interfering RNA (siRNA) approach to knock-
down both homologs. When siLIN28A and siLIN28B were
introduced by transfection, mRNA for these genes was sup-
pressed by 70%–75% as measured by RT-PCR (Figure S3A).
This was also confirmed by western blot (Figure S3B). As a
result of this knockdown,mature let-7 familymiRNAs accu-
mulated, as measured by RT-PCR, relative to transfection of
a nontarget (siNT) control (Figure S3C). Also of note,
siRNAs against both homologs were necessary to observe
an induction of the let-7 family members, demonstrating
their known semiredundant roles in let-7 maturation
(Nam et al., 2011).
Microarray profiling identified many genes differen-
tially expressed as a result of siLIN28A/B dual knock-
down. However, these differentially expressed genes did
not significantly overlap with the original list of probe
sets differentially expressed between PSC-NPCs and
their tissue-derived counterparts (Figure S3H; Patterson
et al., 2012), nor were let-7 downstream targets, besides
LIN28A and LIN28B, selectively knocked down (Fig-
ure S3F). In addition, the dual knockdown had no effect
on the propensity to differentiate into neurons or glia
(Figure S3D). These findings suggested that RNAi based
knockdowns can lower LIN28 expression and induce let-
7 maturation, but the resulting subtle let-7 induction
exerted little effect functional effect. The second strategy
to assess the functional relevance of LIN28B in NPC
maturation utilized re-expression in Tissue-NPCs. When
LIN28B was overexpressed in Tissue-NPCs by viral infec-Figure 2. Dynamics of let-7 Expression and Processing between P
(A) RT-PCR for mature let-7 family members normalized against small n
Sno43 were assayed as controls.
(B) Real-time RT-PCR for pre and pri let-7 family members normalized
(C) Real-time RT-PCR for pri-let-7 miRNAs normalized against the rela
(D) miRNA-seq of chromatin-associated primary let-7 family miRNA tr
kilobase measured (RPKM).
(E) Real-time RT-PCR for mature let-7 family miRNAs in PSC-NPCs over
control and was unchanged over passage.
(F) Real-time RT-PCR for primary let-7 family miRNA transcripts in PS
(G) miRNA-seq of chromatin-associated primary let-7 family miRNA
displayed as reads per kilobase measured (RPKM). Data for miRs-10a,
regulation is unique in PSC versus Tissue-NPCs, even over passage, w
graphs represent SEM over three to four technical replicates, and
experiments.
Stem Cell Rtion, mature let-7 levels decreased (Figure S3E), a por-
tion of the differentially expressed genes between Tis-
sue-NPCs and PSC-NPCs were corrected (Figure S3H),
including some let-7 target genes (Figure S3F). Impor-
tantly, neurogenesis was promoted at the expense of
gliogenesis upon induction of LIN28B in Tissue-NPCs
(Figure S3G).
Direct Manipulation of let-7 Levels Alters Cell Fate in
Neural Progenitors
Previous studies either did not directly address the role of
let-7 in LIN28-mediated developmental progression or
ruled it out altogether (Balzer et al., 2010; Yuan et al.,
2012). To assay whether let-7 miRNAs play a role
in Tissue-NPCs, we introduced antagomirs against let-7b
and let-7g. Microarray analysis on two independent ex-
periments demonstrated that HMGA2 specifically was
strongly induced by antagomirs compared to nonspecific
controls at both the RNA and protein levels (Figures 3A
and 3B). Looking at global gene expression, 649 probe
sets were differentially expressed between let-7b/g antago-
mir-treated and nontarget controls (antag CTRL). Of these
probe sets, 181 overlapped with previous comparisons be-
tween PSC- and Tissue-NPCs (p = 3.723 1055, Figure 3C),
and let-7 targets were specifically increased in these cells as
expected (Figure 3D). Furthermore, Tissue-NPCs trans-
fected with let-7b/g antagomirs were significantly more
similar to PSC-NPCs than antag-CTRL-transfected cells
on a global transcriptome level as measured by Pearson
correlation (Figure 3E). Together, these data indicated
that levels of let-7 in PSC- and Tissue-NPCs play a role in
the transcriptional disparity between these sources of
NPCs, and that manipulation of let-7 levels can shrink
the dissimilarity between them. Finally, when antagomirs
against let-7b/g were introduced into Tissue-NPCs, they
became significantly more neurogenic and less gliogenic
(Figure 3F; p < 0.005).SC-NPCs and Tissue-NPCs
ucleolar RNA U6 in two PSC-NPCs and two Tissue-NPCs. miR-15a and
against small nucleolar RNA U6.
tive levels of GAPDH in each cell type.
anscripts between PSC-NPCs and Tissue-NPCs displayed as reads per
three passages normalized against U6. Sno43 was run as a negative
C-NPCs over three passages normalized against U6.
transcripts in PSC-NPCs over two passages (n = 2 for each group)
10b, 15a, and 15b are shown to indicate that let-7 transcriptional
here let-7a1, a2, b, c, and e were induced. Error bars in all RT-PCR
results shown are representative of at least three independent
eports j Vol. 3 j 758–773 j November 11, 2014 j ª2014 The Authors 763
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Figure 3. A Role for LIN28/let-7 in the Developmental Progression of Human Tissue-NPCs
(A) Averaged robust multiarray average (RMA) normalized expression of selected let-7 target genes in Tissue-NPCs transfected with let-7b/
g antagomiRs or nontargeted control antagomiRs by gene expression microarray. Error bars represent SEM across two biological replicates.
(B) Immunostaining for HMGA2 in Tissue-NPCs showed that let-7 antagomirs induce HMGA2 at the protein level.
(C) Venn diagram demonstrating the original differences identified by Patterson et al. (2012) (yellow) and the overlap with gene
expression differences (>1.54-fold change) between let-7b/g antagomirs versus nonspecific control (antagCTRL) in Tissue-NPCs (green;
n = 2).
(D) Overlap of published and predicted let-7 targets with genes changed after transfection of Tissue-NPCs with let-7b/g antagomiRs or
nontargeted control antagomiRs measured by gene expression microarray.
(E) Pearson correlations of global gene expression similarity between Tissue-NPCs, Tissue-NPCs transfected with let-7b/g antagomiRs or
nontargeted control antagomiRs, and PSC-NPCs.
(F) Immunofluorescence (LEFT) and quantification (RIGHT) for TUJ1 (neurons) and GFAP (glia) on Tissue-NPCs differentiated for 3 weeks in
growth factor withdrawal following transfection with let-7b/g antagomirs or antag CTRL. p value was calculated with Student’s t test for at
least 1,200 cells across eight to ten fields of view. Error bars represent SEM over fields of view, and results shown are representative of at
least three independent experiments. Scale bar, 100 mm.
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be regulated by let-7, mature oligonucleotides (mimics)
for let-7b and let-7g were transfected into PSC-NPCs.
Several let-7 targets (LIN28A, LIN28B, HMGA2, IGF2BP1,
and PLAGL2) were suppressed as measured by microarray
profiling (Figure 4A). Global expression analysis of the of
let-7 mimic-treated NPCs over two independent experi-
ments identified 331 probe sets differentially expressed
between let-7b/g-transfected PSC-NPCs over respective
nonspecific mimic control (miCTRL). Furthermore, among
the transcriptional differences observed between these two
conditions a significant number overlapped with the orig-
inal list of genes differentially expressed between PSC- and
Tissue-NPCs (p = 3.76 3 1046, Figure 4B). Focusing on
direct let-7 downstream targets, expression profiling deter-
mined that not onlywere let-7 target genes overrepresented
in the data, but they were specifically downregulated in let-
7b/g-transfected NPCs over miCTRLs (Figure 4C). Further-
more, let-7b/g-transfected PSC-NPCs were significantly
more similar to 16–19 week tissue-NPCs than miCTRL-
transfected PSC-NPCs on a transcriptome level asmeasured
by Pearson correlation (Figure 4D). Following let-7 induc-
tion, the PSC-NPCs were differentiated for 3 weeks in
growth factor withdrawal media. miCTRL-transfected
NPCs overwhelmingly produced TUJ1+ neurons, whereas
only rare GFAP+ cells were found. When let-7b/g mimics
were transfected prior to differentiation, the PSC-NPCs
were slightly less neurogenic and significantly more glio-
genic (Figure 4E; p = 3.58E05).
Taken together, experiments that employed direct regu-
lation of let-7 levels showed significant effects in both
PSC- and Tissue-NPCs at both themolecular and functional
levels, whereas attempts to manipulate LIN28A/B yielded
more subtle effects. This observation is summarized in Fig-
ure S3, where manipulation of LIN28A/B only showed
modest effects on both gene expression and differentiation
in NPCs (Figures S3G and S3H). Instead, direct manipula-
tion of let-7 clearly shows that this miRNA family can con-
trol the fate of NPCs (Figures 3 and 4), in contrast to what
was shown in a murine model (Balzer et al., 2010).
let-7 Acts through HMGA2 to Control Cell Fate
We hypothesized that the key let-7 target genes responsible
for cell fate in our model should show differences in gene
expression levels in experimental settings presented here
where NPC fate was affected (Figures 1A, 4E, and 5F). Tak-
ing the genes changed in every experimental model we
produced that correlated with changes in neurogenesis
versus gliogenesis, we narrowed the list of candidate genes.
We furthered narrowed the list by taking gene expression
data from the Allen Brain Atlas to identify genes changed
from the pregliogenic state to the gliogenic stage (8–9weeks
PCW versus 16–18 weeks postconception) (Figure 6A). JustStem Cell Rsix genes appeared to have expression patterns that corre-
late with the switch from neurogenesis to gliogenesis in
all these settings (Figure 5A). Of these six genes, two were
predicted let-7 target genes (HMGA2 and GABBR2), but
only HMGA2 has been implicated in neurogenesis (Sano-
saka et al., 2008). HMGA2 was shown to affect cell fate in
the murine brain (Nishino et al., 2008; Sanosaka et al.,
2008) as well as various tissues (Monzen et al., 2008; Yu
et al., 2013) and is thought to be mostly expressed prena-
tally (Ayoubi et al., 1999; Gattas et al., 1999). We found
that HMGA2 was among the genes whose expression was
limited to fetal brain prior to 10 weeks of gestation, just
prior to the surge of gliogenesis predicted by the Allen
Database (Figure 1F).
A closer look at HMGA2 transcription shows that at least
eight transcripts are produced from this locus. One of these
transcripts contains a large 30 UTR that contains six let-7
binding sites, whereas the other transcripts are predicted
to be much less sensitive to suppression by let-7. Reanalysis
of expression analysis by array with various probe sets
that each recognize distinct transcripts showed that the
dominant transcript expressed contains multiple let-7 sites
(identified by 208025_s_at), and that this is the only one
affected by let-7manipulation (data not shown; Figure 5B).
Furthermore, this particular transcript is the only one differ-
entially expressed between PSC- and Tissue- NPCs (Fig-
ure 5B). The difference in expression of HMGA2 between
Tissue- and PSC- NPCs was also obvious at the protein level
(Figure 5C). Taken together, these data suggested that sup-
pression of HMGA2 levels by induction of let-7 correlated
with the switch from neurogenesis to gliogenesis in the ner-
vous system. To directly test the role ofHMGA2 in the devel-
opmental progressionof PSC-NPCs,we silenced this geneby
RNAi prior to terminal differentiation. Three distinct siRNAs
were used (a–c), and just one of them (siHMGA2b) was pre-
dicted to target the long isoform with let-7 sites. HMGA2
message was suppressed by this method at both the RNA
(Figure 5D, left) and protein levels (Figure 5D, right). As
with induction of let-7 mimics, suppression of HMGA2
significantly induced gliogenesis in PSC-NPCs (Figure 5E).
The Notch Pathway Is a Key Effector of let-7 in
Gliogenesis
Profiling RNA expression after HMGA2 KD uncovered a
modest number of genes changed. Intersection of these
genes with those that were changed during human neuro-
genesis (Allen Database) or in Tissue-NPCs where let-7 was
inhibited by antagomirs found just two genes consistently
altered (HES5 and USP44)(Figure 6A). Significantly, HES5 is
a key target gene and effector of the NOTCH pathway, and
perhaps the best known regulator of gliogenesis in mice
(Hojo et al., 2000; Kageyama and Ohtsuka, 1999; Ka-
geyama et al., 2008; Ohtsuka et al., 1999, 2001). RT-PCReports j Vol. 3 j 758–773 j November 11, 2014 j ª2014 The Authors 765
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Figure 4. Direct Introduction of let-7 miRNAs Affects Developmental Progression of PSC-NPCs
(A) Averaged RMA normalized expression of selected let-7 target genes in PSC-NPCs transfected with let-7b/g mimics or nontargeted
control miRNAs by gene expression microarray. Error bars represent SEM across two biological replicates.
(B) Venn diagram demonstrating the original differences identified by Patterson et al. (2012) (yellow), and the overlap with gene
expression differences (>1.54-fold change) between let-7b/g mimics versus nonspecific control (miCTRL) in PSC-NPCs (red; n = 2).
(C) Overlap of published and predicted let-7 targets with genes changed after transfection of PSC-NPCs with let-7b/gmimics or nontargeted
control miRNAs measured by gene expression microarray.
(D) Pearson correlations of global gene expression similarity between PSC-NPCs, PSC-NPCs transfected with let-7b/gmimics or nontargeted
control miRNAs, and Tissue-NPCs.
(E) Immunofluorescence (left) and quantification (right) for TUJ1 (neurons) and GFAP (glia) on PSC-NPCs differentiated for 3 weeks in
growth factor withdrawal following transfection with let-7b/g mimics or miCTRL. p value indicated reflects Student’s t test for at least 800
cells in multiple wells and across six fields of view. Error bars represent SEM over fields of view, and results shown are representative of at
least three independent experiments. Scale bar, 100 mm.
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decreased HES5 levels, suggesting a functional correlation
between the two (Figure 6B). This correlation did not
appear to be due to a difference in the activity of NOTCH,
as both PSC and Tissue-NPCs showed similar activity (Fig-
ure 6C). Although NOTCH signaling has been shown to
either promote or inhibit gliogenesis depending on the
context, in our human model abrogation of all NOTCH
signaling with gamma-secretase inhibitor (DAPT) stimu-
lated gliogenesis and suppressed neuronal differentiation
(Figure 6D).
Using the Allen database, it is clear that HES5 is coex-
pressed with HMGA2 at 8–11 weeks of gestation just prior
onset of gliogenesis, and expression of both genes drop
significantly thereafter (Figure 6E). On the other hand,
most other NOTCH effectors did not significantly change
over the same time (Figure S4A). Expression patterns for
HES5 across nine different human cell types representing
derivatives of all three germ layers suggested that HES5 is
restricted to the nervous system, whereas the other HES/
HEY family members had a more widespread distribution
throughout various organs (Figures 6F and S4B). This anal-
ysis also showed that PSC-NPCs expressed the highest
levels of HES5, followed by lower expression in Tissue-
NPCs, which were more gliogenic (Figure 1A; Patterson
et al., 2012).
In order to functionally probe for a link between HES5
and let-7, this miRNA was experimentally abrogated in
Tissue-NPCs with antagomirs while suppressing HES5 in-
duction with siRNA. As shown above (Figure 3F), suppres-
sion of let-7s with antagomirs increased neurogenesis and
decreased gliogenesis in Tissue-NPCs, but when HES5 in-
duction was simultaneously blocked by siRNA (Figure 6G),
this effect was lost (Figure 6H). This result was consistent
with the described role for HES5 in murine neural develop-
ment in the absence of LIF, whereas, in the presence of LIF,
HES5 has a progliogenic role (Chambers et al., 2001;
Chenn, 2009; Hirabayashi and Gotoh, 2005).
As an AT-hook binding protein, HMGA2 is well known
to be broadly associated with chromatin. To begin to
understand why HMGA2 expression strongly correlated
with HES5 levels in NPCs, we probed whether HMGA2
can regulate access of NICD/RBPj transcriptional com-
plexes to theHES5 promoter in response to NOTCH activa-
tion. Chromatin immunoprecipitation (ChIP) for NICD
uncovered significant binding to two RBP binding sites
within the HES5 regulator region (Figure 6I), as expected
in cells with strong NOTCH activation (Figure 6C). On
the other hand, when HMGA2 expression was abrogated
by siRNA, NICD did not appear to significantly associate
with these same sites, consistent with the notion that
HMGA2 plays a role in regulating access of NICD to the
HES5 promoter.Stem Cell RThe let-7 Effect on Gliogenesis Extends to
Oligodendrocyte Formation
The fact that induction of let-7 drove PSC-NPCs toward a
more astrocytic fate suggested that let-7 could play an
important role in developmental switches. In the same
vein, established protocols to generate oligodendrocytes
with PSC-NPCs normally take at least 17 weeks (Stacpoole
et al., 2013; Wang et al., 2013), which is akin to the time
it takes to produce them in utero (Figure 1F). Using one
of these protocols, we observed oligodendrocyte progeni-
tors (OPCs) and mature oligodendrocytes after just 6–
7weeks of culture, but only in PSC-NPCs cultures following
let-7 induction at the NPC stage (Figure 7). These cells were
judged to be bona fide oligodendrocytes on the basis of co-
expression of O4 and Myelin Basic Protein (MBP) in
confocal imaging. This result again suggested that let-7
can play a role in the developmental maturity of PSC-
NPCs and provides an approach to speed the generation
of astrocytes and oligodendrocytes from human PSCs.DISCUSSION
The critical advance of this study is definitively showing
that let-7 levels not only correlate with developmental pro-
gression in the human nervous system, but also serve to
functionally drive the transition. Furthermore, whereas
the let-7 target gene HMGA2 had previously been shown
to promote neurogenesis in murine NPCs, we showed
here that this is also the case for humans as well. Finally,
we provide evidence that the mechanism by which let-7
miRNAs drives progression in the nervous system is by
altering expression of a key NOTCH effector gene HES5.
This NOTCH effector, and NOTCH signaling in general,
has been shown to be a promoter of gliogenesis in murine
models, whereas our data suggest a proneurogenic role.
This discrepancy could be due to several obvious differ-
ences in context: murine versus human models, the pres-
ence or absence of LIF signaling, and/or in vitro versus
in vivo settings. Nevertheless, the effect in this human
setting was clear: inhibiting NOTCH activity generated
NPCs that went from negligible numbers to a state where
over 10% of differentiated cells were astrocytes. We did
not try the converse experiment, inducing NOTCH activ-
ity, because it appeared as though all NPCs tested, whether
neurogenic or gliogenic, showed considerable NOTCH ac-
tivity. Interestingly, data presented here suggest that no
other NOTCH effectors were affected by let-7 or HMGA2
manipulation, only HES5. These data suggest that the
Notch pathway can be regulated by HES/HEY effectors by
fine-tuning access to the binding sites of its effectors.
However, this study provides only a partial understand-
ing of the relation between HMGA2 and regulation ofeports j Vol. 3 j 758–773 j November 11, 2014 j ª2014 The Authors 767
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Figure 5. HMGA2 Is a Critical Target of let-7 in Developmental Progression
(A) Venn diagram demonstrating the overlap of genes changed in comparisons between neurogenic and gliogenic NPCs in the indicated
contexts. Original list (yellow): n = 7 PSC-NPC lines and n = 5 Tissue-NPC lines; mimic experiment (red): n = 2 for both mimic- and control-
treated lines; antagomir experiment (green): n = 2 for both antag- and control-treated lines.
(legend continued on next page)
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A Role for let-7 in Human Developmental ProgressionNotch signaling. This is due in part to a poorly defined
binding pattern of HMGA2 throughout the genome. It is
known to be abundant when expressed during develop-
ment and, as an AT-binding protein, can in theory bind
nearly the entire genome. Thus, whereas we show here
that the expression of HMGA2 appears to affect access of
NICD to the HES5 promoter, it is unclear whether this is
due to direct binding at this locus, or a general effect on
chromatin compaction.
This study also highlights a role for transcriptional con-
trol of let-7 miRNAs in development. It was thought that
primary let-7 transcription occurred at a constant level,
and that levels of mature let-7 were strictly a matter of
LIN28 activity. However, data provided here clearly demon-
strate that let-7b is regulated at the transcriptional level
even in cells that do not express LIN28A/B. Our data sug-
gest that, developmentally, one let-7 family member (pri-
let-7b) is induced at the transcriptional level prior to the
loss of LIN28A/B protein and may be a key driver of
LIN28A/B suppression as gliogenesis is initiated. It will be
important to determine whether the methods developed
here to facilitate developmental progression also apply to
cells that have been transplanted into tissue.EXPERIMENTAL PROCEDURES
Cell Culture
Undifferentiated hPSC lines HSF1, H9, and xiPSC2 were main-
tained as previously described (Lowry et al., 2008) and in accor-
dance with UCLA ESCRO. Neural progenitors were derived
through formation of neural rosettes and maintained and further
differentiated as described (Karumbayaram et al., 2009). NPCs
were derived from fetal tissue (either brain or spinal cord) as
described. All NPCs were judged to be pure by immunostaining
as described (Patterson et al., 2012) (Figure S1).
Transfection
siRNAs (Thermo Dharmacon), let-7mimics (Thermo Dharmacon),
and let-7 antagomirs (Thermo Dharmacon ‘‘inhibitors’’) were trans-
fected with Lipofectamine RNAiMAX (Invitrogen) at a ratio of 5 ml
lipofectamine:20 nM siRNA or 5 ml lipofectamine:40 nMmimic or
antagomirs for each well of a 6-well plate. A reverse transfection
method was used. Briefly, Lipofectamine and oligos were premixed
in 1 ml of OptiMEM (Gibco) for 25 min in the precoated receiving(B) Normalized expression of all probe sets recognizing HMGA2 in cell
only one that recognizes the HMGA2 isoform containing multiple let-
(C) Immunostaining for HMGA2 in PSC and Tissue-derived NPCs.
(D) Real-time RT-PCR and western blot for HMGA2 expression in PSC-N
siRNAs against HMGA2.
(E) Percentage of positive PSC-NPCs transfected with either control s
glial (GFAP) differentiation following 3 weeks growth factor withdr
pendent experiments. At least 1,900 cells were analyzed across at least
these data are representative of at least three independent experime
Stem Cell Rplate. Cells were then passaged with TrypLE (Gibco), resuspended
in1mlofNPCmediawithout antibiotics, andplatedontopof trans-
fectionmedia. Transfectionswere incubated overnight at 37Cafter
which timemediawas replacedwith standardNPC culturingmedia
with antibiotics for the indicated lengths of time. Lentivirus for
CMV-LIN28B-SV40-mCherry (Genecopoeia) or UBC-mCherry
(Kohn lab)wasmadeby theUCLAvector core.NPCswere reverse in-
fected overnight in NPCmedia without antibiotic.Immunostaining
PSC-NPCs or Tissue-NPCs differentiated for 3 weeks were passaged
withTrypLE (GIBCO) toglass coverslips2–7daysbeforefixing.Cov-
erslips were fixed and stained using standard protocols as described
(Patterson et al., 2012). Primary antibodies included rabbit3 TUJ1
(1:2,000; Covance), rabbit 3 GFAP (1:1,000; Dako), rabbit 3 S100
(1:1,000; Dako), chicken 3 GFAP (1:2,000, Abcam), mouse 3
MAP2 (1:500; Abcam), rabbit 3 Cleaved Notch1 (Val1744) (1:500;
Cell Signaling Technologies), rabbit3 LIN28A (1:300; Cell Signal),
rabbit 3 LIN28B (1:300; Cell Signal), rabbit 3 HMGI-C (HMGA2)
(1:200, Santa Cruz Biotechnology), mouse 3 O4 (1:300; R&D Sys-
tems), rat 3MBP (1:50; Abcam), mouse 3 A2B5 (1:1,000; Abcam).
All images were captured on a Zeiss microscope using Axiovision
software (Zeiss) for image capture. GFAP or TUJ1 positive cells
were counted using ImageJ software as a percentage of the total
DAPI-labeled nuclei or as a percentage of themCherry+ cells within
the field. Average percentage positive cells and SEMwas calculated
over at least six fields of view. Western blot analysis was performed
using standard procedures as described (Lowry et al., 2005). Primary
western blot antibodies include rabbit 3 HMGI-C (1:500; Santa
Cruz), rabbit 3 LIN28A (1:500; Cell Signal), rabbit 3 LIN28B
(1:500; Cell Signal), and mouse3 actin (1:1,000).
Additional materials and methods can be found in the Supple-
mental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, and two tables and can be found with this
article online at http://dx.doi.org/10.1016/j.stemcr.2014.08.015.
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Figure 6. let-7/HMGA2 Regulates Notch Sensitivity through HES5
(A) Venn diagram demonstrating overlap of genes changed in comparisons between neurogenic and gliogenic NPCs in the indicated
contexts.
(B) RT-PCR for relative expression after siRNA transfection to suppress HMGA2 expression.
(C) PSC-NPCs and Tissue-NPCs show similar levels of nuclear NICD accumulation suggesting that both have similar activation of the NOTCH
pathway. Scale bar, 100 mm.
(D) Using a gamma-secretase inhibitor to block NOTCH activation decreases neuronal differentiation and induces gliogenesis as measured
by MAP2 and GFAP staining and quantification. Scale bar, 100 mm.
(E) Transcription of HMGA2 and HES5 quantified by RNA-seq across the developing human brain.
(F) Gene expression data taken from an in-house database of a variety of human cell types suggests that HES5 is mostly expressed in the
nervous system, whereas all the other family members are scattered throughout various types of cells from different organs (Log2 scale,
RMA transformation).
(G) siRNA silencing of HES5 shows a 40% knockdown of message compared to scramble control.
(H) As shown previously in Figure 5E, inhibition of let-7 with antagomirs increased neurogenesis at the expense of gliogenesis. Silencing
HES5 blocks this effect demonstrating a clear link between let-7 and HES5 activity in neurogenesis. *Student’s t test p < 0.05 for n > 450
cells in multiple wells. Paired t tests were performed for each manipulation, and only those with significant changes were indicated by *.
Error bars represent SEM over technical replicates. Results shown are representative of at least three independent experiments.
(legend continued on next page)
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Figure 7. Generation of Oligodendro-
cytes Is Facilitated by Induction of let-7
(A) At 6 weeks of differentiation toward the
oligodendrocyte lineage, OPC markers were
identified by immunostaining and quanti-
fied in (B).
(B) Quantification of results presented in
(A).
(C) Following at least 6 weeks of differen-
tiation in either base or glial induction
medium, mature oligodendrocytes were
identified by immunostaining and quanti-
fied in (D). The bottom panels followed a
glial induction protocol (Wang et al., 2013)
and produced oligodendrocytes after just
6.5 weeks, again, only with let-7 induction
at the NPC stage prior to directed differen-
tiation. At 7.5 weeks, the number of oligo-
dendrocytes produced was considerably
larger. Scale bar, 100 mm.
(D) A quantification of oligodendrocytes in
each condition at two time points in each
well. Cells were judged as bona fide oligo-
dendrocytes if positive for both O4 and
MBP.
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